{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T02:51:13Z","timestamp":1791168673861,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T00:00:00Z","timestamp":1775952000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T00:00:00Z","timestamp":1775952000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82204243"],"award-info":[{"award-number":["82204243"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Young Talent Project of Yunnan Revitalization Talent Support Program","award":["XDYC-QNRC-2023-0140"],"award-info":[{"award-number":["XDYC-QNRC-2023-0140"]}]},{"name":"Yunnan Fundamental Research Project","award":["202501AT070303"],"award-info":[{"award-number":["202501AT070303"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"DOI":"10.1007\/s11030-026-11547-w","type":"journal-article","created":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T10:18:42Z","timestamp":1775989122000},"page":"7907-7927","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Design, synthesis, characterization and exploration of anti-HBV activity of matrine-adenine hybrids"],"prefix":"10.1007","volume":"30","author":[{"given":"Meng-Fan","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou-Fei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong-Tao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,12]]},"reference":[{"key":"11547_CR1","doi-asserted-by":"publisher","first-page":"4253","DOI":"10.1021\/acs.jmedchem.3c00173","volume":"66","author":"W Zhang","year":"2023","unstructured":"Zhang W, Guo L, Liu H, Wu G, Shi H, Zhou M, Zhang Z, Kou B, Hu T, Zhou Z, Xu Z, Zhou X, Zhou Y, Tian X, Yang G, Qiu H, Ottaviani G, Xie J, Mayweg AV, Shen HC, Zhu W (2023) Discovery of Linvencorvir (RG7907), a hepatitis B virus core protein allosteric modulator, for the treatment of chronic HBV infection. J Med Chem 66:4253\u20134270. https:\/\/doi.org\/10.1021\/acs.jmedchem.3c00173","journal-title":"J Med Chem"},{"key":"11547_CR2","doi-asserted-by":"publisher","first-page":"105643","DOI":"10.1016\/j.antiviral.2023.105643","volume":"216","author":"J Yu","year":"2023","unstructured":"Yu J, Shen Z, Chen S, Liu H, Du Z, Mao R, Wang J, Zhang Y, Zhu H, Yang S, Li J, Wu J, Dong M, Zhu M, Huang Y, Li J, Yuan Z, Xie Y, Lu M, Zhang J (2023) Inhibition of HBV replication by EVA1A via enhancing cellular degradation of HBV components and its potential therapeutic application. Antivir Res 216:105643. https:\/\/doi.org\/10.1016\/j.antiviral.2023.105643","journal-title":"Antivir Res"},{"key":"11547_CR3","doi-asserted-by":"publisher","first-page":"115128","DOI":"10.1016\/j.ejmech.2023.115128","volume":"249","author":"H Yang","year":"2023","unstructured":"Yang H, Yao W, Yang J (2023) Overview of the development of HBV small molecule inhibitors. Eur J Med Chem 249:115128. https:\/\/doi.org\/10.1016\/j.ejmech.2023.115128","journal-title":"Eur J Med Chem"},{"key":"11547_CR4","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jhep.2012.02.010","volume":"57","author":"European Association for the Study of the Liver","year":"2012","unstructured":"European Association for the Study of the Liver (2012) EASL clinical practice guidelines: management of chronic hepatitis B virus infection. J Hepatol 57:167\u2013185. https:\/\/doi.org\/10.1016\/j.jhep.2012.02.010","journal-title":"J Hepatol"},{"key":"11547_CR5","doi-asserted-by":"publisher","first-page":"106192","DOI":"10.1016\/j.bioorg.2022.106192","volume":"129","author":"S Wang","year":"2022","unstructured":"Wang S, Ren Y, Li Q, Wang Y, Jiang X, Xu S, Zhang X, Zhao S, Bradley DP, Woodson ME, Zhao F, Wu S, Li Y, Tian Y, Liu X, Tavis JE, Zhan P (2022) Design, synthesis, and biological evaluation of novel sulfamoylbenzamide derivatives as HBV capsid assembly modulators. Bioorg Chem 129:106192. https:\/\/doi.org\/10.1016\/j.bioorg.2022.106192","journal-title":"Bioorg Chem"},{"key":"11547_CR6","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.jhep.2021.04.040","volume":"75","author":"T Berg","year":"2021","unstructured":"Berg T, Lampertico P (2021) The times they are a-changing \u2013 a refined proposal for finite HBV nucleos(t)ide analogue therapy. J Hepatol 75:474\u2013480. https:\/\/doi.org\/10.1016\/j.jhep.2021.04.040","journal-title":"J Hepatol"},{"key":"11547_CR7","doi-asserted-by":"publisher","first-page":"105482","DOI":"10.1016\/j.antiviral.2022.105482","volume":"209","author":"F Ren","year":"2023","unstructured":"Ren F, Tan M, Jerome PLN, Guo WA, Yu YS, Zhang H, Ren JH, Tao CS, Zhang J, Hong LH, Wong VKW, Law BYK, Chen J (2023) Ciliatoside A, isolated from Peristrophe japonica, inhibits HBsAg expression and cccDNA transcription by inducing autophagy. Antivir Res 209:105482. https:\/\/doi.org\/10.1016\/j.antiviral.2022.105482","journal-title":"Antivir Res"},{"key":"11547_CR8","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/liv.13307","volume":"37","author":"B Testoni","year":"2017","unstructured":"Testoni B, Durantel D, Zoulim F (2017) Novel targets for hepatitis B virus therapy. Liver Int 37:33\u201339. https:\/\/doi.org\/10.1111\/liv.13307","journal-title":"Liver Int"},{"key":"11547_CR9","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1080\/17460441.2017.1255195","volume":"12","author":"L Tang","year":"2017","unstructured":"Tang L, Zhao Q, Wu S, Cheng J, Chang J, Guo JT (2017) The current status and future directions of hepatitis B antiviral drug discovery. Expert Opin Drug Discov 12:5\u201315. https:\/\/doi.org\/10.1080\/17460441.2017.1255195","journal-title":"Expert Opin Drug Discov"},{"key":"11547_CR10","doi-asserted-by":"publisher","first-page":"130110","DOI":"10.1016\/j.bmcl.2025.130110","volume":"119","author":"H Xu","year":"2025","unstructured":"Xu H, Li B, Tang K, Yang J, Zhan P (2025) Nucleoside antiviral agents with atypical structures and new targets. Bioorg Med Chem Lett 119:130110. https:\/\/doi.org\/10.1016\/j.bmcl.2025.130110","journal-title":"Bioorg Med Chem Lett"},{"key":"11547_CR11","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.apsb.2015.07.002","volume":"5","author":"C Wang","year":"2015","unstructured":"Wang C, Song Z, Yu H, Liu K, Ma X (2015) Adenine: an important drug scaffold for the design of antiviral agents. Acta Pharm Sin B 5:431\u2013441. https:\/\/doi.org\/10.1016\/j.apsb.2015.07.002","journal-title":"Acta Pharm Sin B"},{"key":"11547_CR12","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/0166-3542(92)90084-I","volume":"19","author":"JE Starrett Jr","year":"1992","unstructured":"Starrett JE Jr, Tortolani DR, Hitchcock MJ, Martin JC, Mansuri MM (1992) Synthesis and in vitro evaluation of a phosphonate prodrug: bis (pivaloyloxymethyl) 9-(2-phosphonylmethoxyethyl)adenine. Antivir Res 19:267\u2013273. https:\/\/doi.org\/10.1016\/0166-3542(92)90084-I","journal-title":"Antivir Res"},{"key":"11547_CR13","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1134\/S1607672924600787","volume":"520","author":"AA Zenchenko","year":"2025","unstructured":"Zenchenko AA, Semenova YD, Naberezhnaya ER, Gumennaya YD, Lipatova AV, Oslovsky VE (2025) New N6-substituted adenine derivatives with high antiviral activity against RNA-containing viruses. Dokl Biochem Biophys 520:38\u201341. https:\/\/doi.org\/10.1134\/S1607672924600787","journal-title":"Dokl Biochem Biophys"},{"key":"11547_CR14","doi-asserted-by":"publisher","first-page":"16530","DOI":"10.1021\/acs.jmedchem.1c01104","volume":"64","author":"N Losada","year":"2021","unstructured":"Losada N, Ruiz FX, Curreli F, Gruber K, Pilch A, Das K, Debnath AK, Arnold E (2021) HIV-1 gp120 antagonists also inhibit HIV-1 reverse transcriptase by bridging the NNRTI and NRTI sites. J Med Chem 64:16530\u201316540. https:\/\/doi.org\/10.1021\/acs.jmedchem.1c01104","journal-title":"J Med Chem"},{"key":"11547_CR15","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1055\/s-2007-969179","volume":"52","author":"CH Cho","year":"1986","unstructured":"Cho CH, Chuang CY, Chen CF (1986) Study of the antipyretic activity of matrine. a lupin alkaloid isolated from Sophora subprostrata. Planta Med 52:343\u2013345. https:\/\/doi.org\/10.1055\/s-2007-969179","journal-title":"Planta Med"},{"key":"11547_CR16","doi-asserted-by":"publisher","first-page":"153289","DOI":"10.1016\/j.phymed.2020.153289","volume":"77","author":"N Sun","year":"2020","unstructured":"Sun N, Zhang H, Sun P, Khan A, Guo J, Zheng X, Sun Y, Fan K, Yin W, Li H (2020) Matrine exhibits antiviral activity in a PRRSV\/PCV2 co-infected mouse model. Phytomedicine 77:153289. https:\/\/doi.org\/10.1016\/j.phymed.2020.153289","journal-title":"Phytomedicine"},{"key":"11547_CR17","doi-asserted-by":"publisher","first-page":"e2001066","DOI":"10.1002\/cbdv.202001066","volume":"18","author":"JC Li","year":"2021","unstructured":"Li JC, Dai WF, Zhou XQ, Rao KR, Zhang ZJ, Liu D, Chen XQ, Li RT, Li HM (2021) Matrine-type alkaloids from the seeds of Sophora alopecuroides and their potential anti-inflammatory activities. Chem Biodivers 18:e2001066. https:\/\/doi.org\/10.1002\/cbdv.202001066","journal-title":"Chem Biodivers"},{"key":"11547_CR18","doi-asserted-by":"publisher","first-page":"113954","DOI":"10.1016\/j.phytochem.2023.113954","volume":"218","author":"D Luo","year":"2024","unstructured":"Luo D, Zou JW, Wang JH, Tian H, Xie HY, Zhu TX, Zhu HH, Deng LM, Fan CL, Wang H, Wang GC, Zhang YB (2024) Undescribed matrine-type alkaloids from Sophora alopecuroides with anti-inflammatory activity. Phytochemistry 218:113954. https:\/\/doi.org\/10.1016\/j.phytochem.2023.113954","journal-title":"Phytochemistry"},{"key":"11547_CR19","doi-asserted-by":"publisher","first-page":"112842","DOI":"10.1016\/j.phytochem.2021.112842","volume":"190","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Dong SW, Gao DD, Du XY, Xie YQ, Xia XS, Li RT (2021) Unusual matrine\u2013adenine hybrids isolated from Sophora davidii and their inhibitory effects on human cytomegalovirus. Phytochemistry 190:112842. https:\/\/doi.org\/10.1016\/j.phytochem.2021.112842","journal-title":"Phytochemistry"},{"key":"11547_CR20","doi-asserted-by":"publisher","first-page":"114514","DOI":"10.1016\/j.phytochem.2025.114514","volume":"236","author":"TT Liu","year":"2025","unstructured":"Liu TT, Xie MF, Yang QQ, Li RT, Zhang ZJ (2025) Sophormodines A\u2212C, three alkaloids with antiviral activities against the HBV from the seeds of the Tibetan medicine plant Sophora moorcroftiana. Phytochemistry 236:114514. https:\/\/doi.org\/10.1016\/j.phytochem.2025.114514","journal-title":"Phytochemistry"},{"key":"11547_CR21","doi-asserted-by":"publisher","first-page":"142498","DOI":"10.1016\/j.molstruc.2025.142498","volume":"1340","author":"MF Xie","year":"2025","unstructured":"Xie MF, Liu TT, Yang QQ, Li RT, Zhang ZJ (2025) Sophormodines D-K, matrine-type alkaloids with anti-HBV activity from the seeds of Tibetan medicine Sophora moorcroftiana. J Mol Struct 1340:142498. https:\/\/doi.org\/10.1016\/j.molstruc.2025.142498","journal-title":"J Mol Struct"},{"key":"11547_CR22","doi-asserted-by":"publisher","first-page":"452","DOI":"10.2174\/1573412913666161110111715","volume":"13","author":"XY Xiong","year":"2017","unstructured":"Xiong XY, Yu HJ, Nan YF (2017) A highly sensitive chemiluminescence method and application in rapid pharmacokinetic study of matrine in rat plasma. Curr Pharm Anal 13:452\u2013461. https:\/\/doi.org\/10.2174\/1573412913666161110111715","journal-title":"Curr Pharm Anal"},{"key":"11547_CR23","doi-asserted-by":"publisher","first-page":"436","DOI":"10.3390\/biom15030436","volume":"15","author":"TT Liu","year":"2025","unstructured":"Liu TT, Xie MF, Liu X, Li RT, Bai Y, Zhang ZJ (2025) Design, synthesis, and bioevaluation of matrine derivatives as potential anti\u2013hepatitis B virus agents. Biomolecules 15:436. https:\/\/doi.org\/10.3390\/biom15030436","journal-title":"Biomolecules"},{"key":"11547_CR24","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1007\/s00044-019-02398-2","volume":"28","author":"Y Xu","year":"2019","unstructured":"Xu Y, Liang P, ur Rashid H, Wu L, Xie P, Wang H, Zhang S, Wang L, Jiang J (2019) Design, synthesis, and biological evaluation of matrine derivatives possessing piperazine moiety as antitumor agents. Med Chem Res 28:1618\u20131627. https:\/\/doi.org\/10.1007\/s00044-019-02398-2","journal-title":"Med Chem Res"},{"key":"11547_CR25","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1111\/cbdd.13512","volume":"95","author":"J Yu","year":"2020","unstructured":"Yu J, Jia H, Guo X, Desta S, Zhang S, Zhang J, Ding X, Liang X, Liu X, Zhan P (2020) Design, synthesis, and evaluation of novel heteroaryldihydropyrimidine derivatives as non-nucleoside hepatitis B virus inhibitors by exploring the solvent-exposed region. Chem Biol Drug Des 95:567\u2013583. https:\/\/doi.org\/10.1111\/cbdd.13512","journal-title":"Chem Biol Drug Des"},{"key":"11547_CR26","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.ejmech.2017.04.048","volume":"136","author":"H Jia","year":"2017","unstructured":"Jia H, Song Y, Yu J, Zhan P, Rai D, Liang X, Ma C, Liu X (2017) Design, synthesis and primary biological evaluation of the novel 2-pyridone derivatives as potent non-nucleoside HBV inhibitors. Eur J Med Chem 136:144\u2013153. https:\/\/doi.org\/10.1016\/j.ejmech.2017.04.048","journal-title":"Eur J Med Chem"},{"key":"11547_CR27","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1002\/hep.25928","volume":"56","author":"PC van Breugel","year":"2012","unstructured":"van Breugel PC, Robert EI, Mueller H, Decorsi\u00e8re A, Zoulim F, Hantz O (2012) Hepatitis B virus X protein stimulates gene expression selectively from extrachromosomal DNA templates. Hepatology 56:2116\u20132124. https:\/\/doi.org\/10.1002\/hep.25928","journal-title":"Hepatology"},{"key":"11547_CR28","doi-asserted-by":"publisher","first-page":"100551","DOI":"10.1016\/j.jhepr.2022.100551","volume":"4","author":"B Qu","year":"2022","unstructured":"Qu B, Nebioglu F, Leuthold MM, Ni Y, Mutz P, Beneke J, Erfle H, Vondran FWR, Bartenschlager R, Urban S (2022) Dual role of neddylation in transcription of hepatitis B virus RNAs from cccDNA and production of viral surface antigen. JHEP Rep 4:100551. https:\/\/doi.org\/10.1016\/j.jhepr.2022.100551","journal-title":"JHEP Rep"},{"key":"11547_CR29","doi-asserted-by":"publisher","first-page":"e2421325122","DOI":"10.1073\/pnas.2421325122","volume":"122","author":"H Tanaka","year":"2025","unstructured":"Tanaka H, Diogo DJ, Jay B, Kita S, Sasaki M, Takeda H, Kishimoto N, Sasaki S, Misumi S, Mizokami M, Neuveut C, Sumikama T, Shibata M, Maenaka K, Machida S (2025) Structural basis of the hepatitis B virus X protein in complex with DDB1. Proc Natl Acad Sci U S A 122:e2421325122. https:\/\/doi.org\/10.1073\/pnas.2421325122","journal-title":"Proc Natl Acad Sci U S A"},{"key":"11547_CR30","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.jcmgh.2018.10.010","volume":"7","author":"K Sekiba","year":"2019","unstructured":"Sekiba K, Otsuka M, Ohno M, Yamagami M, Kishikawa T, Suzuki T, Ishibashi R, Seimiya T, Tanaka E, Koike K (2019) Inhibition of HBV transcription from cccDNA with nitazoxanide by targeting the HBx\u2013DDB1 interaction. Cell Mol Gastroenterol Hepatol 7:297\u2013312. https:\/\/doi.org\/10.1016\/j.jcmgh.2018.10.010","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"11547_CR31","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ejmech.2017.11.028","volume":"143","author":"Y Liu","year":"2018","unstructured":"Liu Y, Peng Y, Lu J, Wang J, Ma H, Song C, Liu B, Qiao Y, Yu W, Wu J, Chang J (2018) Design, synthesis, and biological evaluation of new 1,2,3-triazolo-2\u2032-deoxy-2\u2032-fluoro- 4\u2032-azido nucleoside derivatives as potent anti-HBV agents. Eur J Med Chem 143:137\u2013149. https:\/\/doi.org\/10.1016\/j.ejmech.2017.11.028","journal-title":"Eur J Med Chem"},{"key":"11547_CR32","doi-asserted-by":"publisher","first-page":"28313","DOI":"10.1039\/C6RA24662A","volume":"7","author":"V Abbot","year":"2017","unstructured":"Abbot V, Sharma P, Dhiman S, Noolvi MN, Patel HM, Bhardwaj V (2017) Small hybrid heteroaromatics: resourceful biological tools in cancer research. RSC Adv 7:28313\u201328349. https:\/\/doi.org\/10.1039\/C6RA24662A","journal-title":"RSC Adv"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11547-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-026-11547-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11547-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T02:03:31Z","timestamp":1791165811000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-026-11547-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,12]]},"references-count":32,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["11547"],"URL":"https:\/\/doi.org\/10.1007\/s11030-026-11547-w","relation":{},"ISSN":["1573-501X"],"issn-type":[{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,12]]},"assertion":[{"value":"14 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}